130 related articles for article (PubMed ID: 2981539)
1. HNK-1+ cells in non-Hodgkin's lymphoma: lack of relation with transferrin receptor expression on malignant cells.
Schuurman HJ; Kluin PM; de Gast GC; Kater L
Br J Cancer; 1985 Feb; 51(2):171-7. PubMed ID: 2981539
[TBL] [Abstract][Full Text] [Related]
2. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
[TBL] [Abstract][Full Text] [Related]
3. Distribution of HNK-1+ cells in malignant lymphomas.
Mori S; Yamaguchi K; Morita H; Mohri N
Acta Pathol Jpn; 1985 Mar; 35(2):339-50. PubMed ID: 3895822
[TBL] [Abstract][Full Text] [Related]
4. The distribution of cells expressing a natural killer cell marker (HNK-1) in normal human lymphoid organs and malignant lymphomas.
Mori S; Mohri N; Morita H; Yamaguchi K; Shimamine T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 43(3):253-63. PubMed ID: 6137899
[TBL] [Abstract][Full Text] [Related]
5. Natural killer-like cells found in B-cell compartments of human lymphoid tissues.
Banerjee D; Thibert RF
Nature; 1983 Jul 21-27; 304(5923):270-2. PubMed ID: 6346108
[TBL] [Abstract][Full Text] [Related]
6. Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas.
Greil R; Gattringer C; Knapp W; Huber H
Br J Haematol; 1986 Feb; 62(2):293-300. PubMed ID: 3004554
[TBL] [Abstract][Full Text] [Related]
7. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
8. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte subgroups and the activity of human natural killer (HNK) cells in low-grade and high-grade malignant cases of non-Hodgkin lymphoma.
Burger T; Schmelczer M; Molnár L; Fábián G; Szabó A; Tóvári E
Acta Med Hung; 1990; 47(1-2):65-76. PubMed ID: 1704121
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological study of transferrin receptor expression in non-Hodgkin's lymphoma.
Pileri S; Gobbi M; Rivano MT; Martinelli G
Br J Haematol; 1984 Nov; 58(3):501-8. PubMed ID: 6093847
[TBL] [Abstract][Full Text] [Related]
11. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma.
Habeshaw JA; Lister TA; Stansfeld AG; Greaves MF
Lancet; 1983 Mar; 1(8323):498-501. PubMed ID: 6131211
[TBL] [Abstract][Full Text] [Related]
12. [Cells of the phenotype HNK-1 + (CD 57 +) in reactive adenopathies, lymphomas and Hodgkin's disease].
Merlio JP; Caveriviere P; al Saati T; Coindre JM; de Mascarel A; Delsol G
Ann Pathol; 1990; 10(3):166-73. PubMed ID: 1696823
[TBL] [Abstract][Full Text] [Related]
13. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
Krajewski AS; Guy K; Dewar AE; Cossar D
J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
[TBL] [Abstract][Full Text] [Related]
16. [Infiltration pattern of immunocompetent lymphocytes in the tissue of malignant non-Hodgkin's lymphoma: relationship to histological and clinical parameters].
Gattringer C; Radaszkiewicz T; Greil R; Pfaller W; Huber H
Wien Klin Wochenschr; 1985 Mar; 97(5):258-63. PubMed ID: 3873140
[TBL] [Abstract][Full Text] [Related]
17. Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions.
Pizzolo G; Semenzato G; Chilosi M; Morittu L; Ambrosetti A; Warner N; Bofill M; Janossy G
Clin Exp Immunol; 1984 Jul; 57(1):195-206. PubMed ID: 6744669
[TBL] [Abstract][Full Text] [Related]
18. Transferrin receptor and B-lymphoblast antigen--their relationship to DNA synthesis, histology and survival in B-cell lymphomas.
Kvaløy S; Langholm R; Kaalhus O; Michaelsen T; Funderud S; Foss Abrahamsen A; Godal T
Int J Cancer; 1984 Feb; 33(2):173-7. PubMed ID: 6319299
[TBL] [Abstract][Full Text] [Related]
19. An assessment of natural cell-mediated cytotoxicity in patients with malignant lymphoma.
Healy F; Rees RC; Hancock BW
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):775-83. PubMed ID: 2412830
[TBL] [Abstract][Full Text] [Related]
20. Double immunoenzymatic labeling of lymphomatous tissues for both immunologic phenotype and a malignancy-associated nucleolar antigen.
Lu M; Davis FM; Ford RJ
Am J Pathol; 1986 Apr; 123(1):73-8. PubMed ID: 2421582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
